Literature DB >> 15576492

Acute myocardial hypoxia increases BNP gene expression.

J P Goetze1, A Gore, C H Møller, D A Steinbrüchel, J F Rehfeld, L B Nielsen.   

Abstract

It is well established that cardiac failure increases cardiac B-type natriuretic peptide (BNP) expression due to myocardial stretching. However, patients with ischemic heart disease also display increased plasma BNP and proBNP concentrations despite preserved cardiac function. In this study, we examined whether acute myocardial hypoxia increases cardiac BNP expression. Surgical reduction of the blood flow to an area of the anterior ventricular wall in pigs reduced the myocardial oxygen tension from 46 +/- 4 to 13 +/- 5 mmHg. The tissue contents of VEGF and BNP mRNA increased 1.8-fold and 3.5-fold, respectively (n=10, P<0.005) in hypoxic compared with normoxic ventricular myocardium after 2.2 +/- 0.2 h; the magnitude of the increase in BNP mRNA expression was positively correlated with that of VEGF in hypoxic myocardium (r=0.66, P<0.05). In support of a hypoxia-induced increase of BNP gene transcription, the content of a premature BNP mRNA was increased in hypoxic myocardium (4.8-fold, P<0.005) and in freshly harvested ventricular myocytes when kept in culture flasks and oxygen-deprived for 3 h (2.2-fold, P=0.002). ProBNP peptide accumulated in the medium of freshly harvested ventricular myocyte cultures but was undetectable in ventricular myocardium, indicating rapid release of the newly synthesized proBNP peptide. Accordingly, the plasma proBNP concentration increased after 2 h of myocardial hypoxia (P=0.028). Cumulatively, the data suggest that acute hypoxia stimulates cardiac BNP expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15576492     DOI: 10.1096/fj.03-1336fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  36 in total

Review 1.  Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?

Authors:  Irmgard Tegeder; Gerd Geisslinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-04       Impact factor: 3.000

2.  The effect of 18 h of simulated high altitude on left ventricular function.

Authors:  Jesper Kjaergaard; Eric M Snyder; Christian Hassager; Thomas P Olson; Jae K Oh; Bruce D Johnson
Journal:  Eur J Appl Physiol       Date:  2006-09-21       Impact factor: 3.078

Review 3.  Best evidence topic report. Brain natriuretic peptide as a potential marker of acute coronary syndromes.

Authors:  Richard Body; Catherine Roberts
Journal:  Emerg Med J       Date:  2006-05       Impact factor: 2.740

Review 4.  The paradox of low BNP levels in obesity.

Authors:  Aldo Clerico; Alberto Giannoni; Simona Vittorini; Michele Emdin
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

5.  Hypoxia regulates the natriuretic peptide system.

Authors:  Olli Arjamaa; Mikko Nikinmaa
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-09-07

Review 6.  Physiology of natriuretic peptides: The volume overload hypothesis revisited.

Authors:  Olli Arjamaa
Journal:  World J Cardiol       Date:  2014-01-26

7.  Additive Value of B-Type Natriuretic Peptide on Rest Tl-Dipyridamole Stress Tc-Sestamibi Gated Myocardial SPECT in Patients with Normal Left Ventricular Systolic Function.

Authors:  Jung-Ju Sir; Young-Seok Cho; Woo-Young Chung; Bon-Kwon Koo; In-Ho Chae; Dong-Ju Choi; Hyo-Soo Kim; Byung-Hee Oh; Young-Bae Park
Journal:  Cardiol Res Pract       Date:  2010-04-12       Impact factor: 1.866

Review 8.  Regulation of angiogenesis by oxygen sensing mechanisms.

Authors:  Guo-Hua Fong
Journal:  J Mol Med (Berl)       Date:  2009-03-14       Impact factor: 4.599

9.  The role of iNOS-derived NO in the antihypertrophic actions of B-type natriuretic peptide in neonatal rat cardiomyocytes.

Authors:  Tiannan Wang; Ming Yan; Jieyue Li; Xiaoxiang Zheng
Journal:  Mol Cell Biochem       Date:  2007-05-09       Impact factor: 3.396

10.  The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology.

Authors:  Van Kimmenade
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.